MA25509A1 - COMPOSITION FOR THE TREATMENT OF HEPATITIS C - Google Patents

COMPOSITION FOR THE TREATMENT OF HEPATITIS C

Info

Publication number
MA25509A1
MA25509A1 MA26657A MA26657A MA25509A1 MA 25509 A1 MA25509 A1 MA 25509A1 MA 26657 A MA26657 A MA 26657A MA 26657 A MA26657 A MA 26657A MA 25509 A1 MA25509 A1 MA 25509A1
Authority
MA
Morocco
Prior art keywords
hepatitis
treatment
composition
Prior art date
Application number
MA26657A
Other languages
French (fr)
Inventor
Wassyl Nowicky
Original Assignee
Nowicky Wassili
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nowicky Wassili filed Critical Nowicky Wassili
Publication of MA25509A1 publication Critical patent/MA25509A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MA26657A 2000-03-22 2002-05-28 COMPOSITION FOR THE TREATMENT OF HEPATITIS C MA25509A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0048100A AT408719B (en) 2000-03-22 2000-03-22 AGENT FOR TREATING HEPATITIS C

Publications (1)

Publication Number Publication Date
MA25509A1 true MA25509A1 (en) 2002-07-01

Family

ID=3674939

Family Applications (1)

Application Number Title Priority Date Filing Date
MA26657A MA25509A1 (en) 2000-03-22 2002-05-28 COMPOSITION FOR THE TREATMENT OF HEPATITIS C

Country Status (17)

Country Link
JP (1) JP2003527414A (en)
KR (1) KR20020087045A (en)
CN (1) CN1416347A (en)
AT (1) AT408719B (en)
AU (1) AU2001239000A1 (en)
BG (1) BG107088A (en)
BR (1) BR0107211A (en)
CA (1) CA2389173A1 (en)
EA (1) EA200200584A1 (en)
HR (1) HRP20020367A2 (en)
IL (1) IL149314A0 (en)
IS (1) IS6360A (en)
MA (1) MA25509A1 (en)
MX (1) MXPA02004993A (en)
NO (1) NO20022253L (en)
PL (1) PL365000A1 (en)
WO (1) WO2001070203A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH695417A5 (en) * 2001-11-15 2006-05-15 Ddr Wassyl Nowicky Dipl Ing Process for reacting alkaloids.
EP1459753A1 (en) 2003-03-18 2004-09-22 Nowicky, Wassyl, Dipl.-Ing. DDr. Quaternary chelidonine and alkaloid derivatives, process for their preparation and their use in the manufacture of medicaments
EP2083825A4 (en) * 2006-09-26 2009-11-04 Addiction Res Inst Inc Compositions for the treatment of hepatitis c and methods for using compositions for the treatment of hepatitis c
CN106343303A (en) * 2015-07-13 2017-01-25 张如安 Beverage for killing hepatitis B virus
CN106109538A (en) * 2016-07-29 2016-11-16 桂林淮安天然保健品开发有限公司 The pharmaceutical composition for the treatment of hepatitis C

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3128018A1 (en) * 1981-07-13 1983-04-07 Wassyl 1060 Wien Nowicky "METHOD FOR DIAGNOSTICING AND FOR THE THERAPEUTIC TREATMENT OF TUMORS AND / OR INFECTIOUS DISEASES OF DIFFERENT TYPES WITH PREPARATIVE USE OF ALKALOID COMPOUNDS OR THEIR SALTS"
US4970212A (en) * 1982-05-18 1990-11-13 Nowicky Wassili Method of treating human illnesses which compromise the ability to mount an effective immunological response
US4816462A (en) * 1982-05-18 1989-03-28 Nowicky Wassili Method for diagnosing and for the therapeutic treatment of tumors and/or infectious diseases of different types with alkaloid-compounds
PT93772A (en) * 1989-04-17 1991-01-08 Searle & Co PROCESS FOR THE PREPARATION OF COMPOSITIONS FOR THE TREATMENT OF NEOPLASMS, CONTAINING AN ANTI-NEOPLASTIC AGENT, FOR EXAMPLE DOXORUBICIN AND A PROTEIN AGENT TO REDUCE THE SIDE EFFECTS, FOR EXAMPLE CARBETIMER

Also Published As

Publication number Publication date
AU2001239000A1 (en) 2001-10-03
IL149314A0 (en) 2002-11-10
EA200200584A1 (en) 2003-06-26
IS6360A (en) 2002-04-24
MXPA02004993A (en) 2003-10-14
BG107088A (en) 2003-05-30
BR0107211A (en) 2004-01-06
KR20020087045A (en) 2002-11-21
CA2389173A1 (en) 2001-09-27
AT408719B (en) 2002-02-25
ATA4812000A (en) 2001-07-15
NO20022253D0 (en) 2002-05-10
HRP20020367A2 (en) 2004-02-29
WO2001070203A2 (en) 2001-09-27
PL365000A1 (en) 2004-12-27
WO2001070203A3 (en) 2002-09-06
JP2003527414A (en) 2003-09-16
NO20022253L (en) 2002-05-10
CN1416347A (en) 2003-05-07

Similar Documents

Publication Publication Date Title
FR07C0046I2 (en) BETA-L-2'-DESOXY-NUCLEOSIDES FOR THE TREATMENT OF HEPATITIS B
FR20C1039I2 (en) DERIVATIVES OF UK-2A
CY2018020I2 (en) TREATMENT OF ROMRE'S DISEASE
MA27126A1 (en) 3'PROMEDICAMENTS OF 2'-DESOXY- β-L-NUCLEOSIDES
CH1143977H1 (en) 2-Oxy-benzoxazine-4-ones for the treatment of obesity
EE200200716A (en) Compounds for the Treatment of Alzheimer's Disease
MA26207A1 (en) WATER TREATMENT COMPOSITIONS.
MA25823A1 (en) COMPOSITIONS FOR THE TREATMENT OF WATER.
ATE315938T1 (en) 4'-SUBSTITUTED NUCLEOSIDES FOR THE TREATMENT OF HEPATITIS C VIRUS-MEDIATED DISEASES
EE05158B1 (en) 1,5-Benzothiazepines and their use as antilipidemic agents
NO2012018I2 (en) Canakinumab or direct equivalents thereof
DE69912223D1 (en) Methyl methacrylate composition
DE60019158D1 (en) NEW OXABISPIDINE COMPOUNDS FOR THE TREATMENT OF HERZARRYTHMIES
PT1250321E (en) COMPOSITION OF GLIBURIDA
DE60123238D1 (en) COMPOSITIONS FOR THE TREATMENT OF AUTOIMMUNE DISEASES
DE10082139T1 (en) Composition for the treatment of friction pairs
DE69841984D1 (en) COMPOSITION OF NANOCAPSULES FOR THE TREATMENT OF INTRAARTICULAR DISEASES
DZ3014A1 (en) Medicines for the treatment of hypertension.
EE200200632A (en) Preparations containing glucocorticoids for the treatment of bronchopulmonary disorders
DE60008353D1 (en) HEMIHYDRATE OF 16.ALPHA.-BROMOEPIANDROSTERONE
ID25765A (en) COMPOSITION OF SKIN CLEANER
FR2857597B1 (en) USE OF PEPTIDE CONJUGATES FOR THE PREPARATION OF COMPOSITIONS FOR THE PREVENTIVE AND CURATIVE TREATMENT OF ALOPECIA.
MA25509A1 (en) COMPOSITION FOR THE TREATMENT OF HEPATITIS C
DE69913380D1 (en) COMPOSITION FOR THE TREATMENT OF PERIODONTAL DISEASES
FR2800614B1 (en) COMPOSITION FOR THE TREATMENT OF RESPIRATORY INFECTIONS